Zealand Pharma A/s (NASDAQ: ZEAL)
Some price data may be temporarily unavailable.
Zealand Pharma A/s Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zealand Pharma A/s Company Info
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
News & Analysis
With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?
A new, easier-to-administer treatment for severe hypoglycemia has observers and investors wondering where its creators will go next.
3 Top Biotech Stocks to Buy in March
These three healthcare gems have the full attention of our team of experts.
Valuation
Earnings Transcripts
Zealand Pharma A/S (ZEAL) Q3 2020 Earnings Call Transcript
ZEAL earnings call for the period ending September 30, 2020.
Zealand Pharma A/S (ZEAL) Q2 2020 Earnings Call Transcript
ZEAL earnings call for the period ending June 30, 2020.
Zealand Pharma A/S (ZEAL) Q1 2020 Earnings Call Transcript
ZEAL earnings call for the period ending March 31, 2020.
Zealand Pharma A/S (ZEAL) Q4 2019 Earnings Call Transcript
ZEAL earnings call for the period ending December 31, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.